AGNG

Aging Population ETF

Morningstar Rating™ - Overall rating out of 164 Health funds, based on risk-adjusted returns as of 02/28/2026

Key Information

As of Mar 11 2026
Inception Date
05/09/16
Total Expense Ratio
0.50%
Net Assets
$84.61 million
NAV
$36.31
Fact Sheet

ETF Summary

The Global X Aging Population ETF (AGNG) seeks to invest in companies positioned to serve the world’s growing senior population through exposure to health care, pharmaceuticals, senior living facilities and other sectors that contribute to increasing lifespans and extending quality of life in advanced age.

ETF Objective

The Global X Aging Population ETF (AGNG) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Indxx Aging Population Thematic Index.
Trading Details
Distributions

ETF Prices

As of Mar 11 2026
NAV$36.31Daily Change-$0.30-0.82%
Market Price$36.43Daily Change-$0.24-0.65%

Performance History

Fund NAVMarket PriceIndex

Top Holdings

Net Assets (%)TickerNameSEDOLShares HeldMarket Value
Exposure

ETF Characteristics

As of Mar 11 2026
Return on Equity15.90%
Weighted Avg. Market Cap125,389 M
20252026
Price-to-earnings22.6320.13
Price-to-book value3.383.04

ETF Risk Stats

As of Feb 28 2026
VERSUSBETA
S&P 5000.54
NASDAQ-1000.39
MSCI EAFE0.75
MSCI Emg. Mkts0.53
Standard Deviation12.60%

ETF Research

Investing in Pharma: How to Spot Leading Drug Candidates

Investing in Pharma: The Drug Lifecycle

In the Pipeline: Top Drug Candidates for FDA Approval in 2024

ETF Documents